Weight reduction has a significant impact in the cardiovascular outcomes of patients with diabetes; this was proved in many studies that addressed the impact of surgically induced weight reduction on cardiovascular outcomes [17, 18], and more recently by Paul et al. who have shown that cardiovascular outcomes has significantly improved in patients receiving exenatide or exenatide plus insulin compared to those receiving insulin only [19]. Here, INS is linked to diabetes mellitus.